Strategy to Achieve Faster Recanalization for Acute Ischemic Stroke in a University Hospital with Many Constraints

JNET Pub Date : 2019-01-01 DOI:10.5797/jnet.oa.2018-0145
S. Mizuhashi, Azusa Yonezawa, S. Kohyama
{"title":"Strategy to Achieve Faster Recanalization for Acute Ischemic Stroke in a University Hospital with Many Constraints","authors":"S. Mizuhashi, Azusa Yonezawa, S. Kohyama","doi":"10.5797/jnet.oa.2018-0145","DOIUrl":null,"url":null,"abstract":"Objective: It is essential to improve the in-hospital system and arrangement to achieve recanalization as soon as possible in acute cerebral artery occlusion. In Saitama Prefecture, the stroke emergency transport system began to operate in January 2018 under the prefectural government initiative. At our hospital, also, a trial aiming at rapid, safe, and effective recanalization was initiated in August 2017 in a team consisting mainly of doctors and co-medical staff of the Stroke Center. In this report, the results of the 17-month trial are reviewed. Methods: In all, 127 patients with acute cerebral artery occlusion who underwent endovascular treatment between January 2016 and December 2018 (56 treated before and 71 treated after the initiation of the time-reducing trial) were compared. Interdepartmental conferences and simulations were frequently held with participation primarily by physicians, radiology technicians, and nurses, and information about treatments, operations by various professionals, and therapeutic approaches was shared. The diagnostic and therapeutic processes of the cases experienced were also promptly evaluated and modified for improvements. Results: The time from the arrival of the patient to the injection of recombinant tissue plasminogen activator (rt-PA) was significantly reduced from 90 to 75 minutes, time from the arrival to puncture from 99 to 74 minutes, procedure time from 63 to 50 minutes, and time from the arrival to eventual recanalization from 165 to 130 minutes. The rate of effective recanalization was higher after the initiation of the trial (62% vs. 76%), but the difference was not significant. The percentage of patients with a favorable outcome was also higher after the initiation of the trial (25% vs. 39%). Conclusion: The results of this study indicate that the time of emergency treatment for acute cerebral artery occlusion can be shortened even in a large-scale university hospital with many constraints by sharing of information among departments and making sure that the medical staff of stroke center is well-informed of the standardized therapeutic approach. stroke team approach, rapid recanalization, therapeutic time","PeriodicalId":34768,"journal":{"name":"JNET","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JNET","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5797/jnet.oa.2018-0145","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: It is essential to improve the in-hospital system and arrangement to achieve recanalization as soon as possible in acute cerebral artery occlusion. In Saitama Prefecture, the stroke emergency transport system began to operate in January 2018 under the prefectural government initiative. At our hospital, also, a trial aiming at rapid, safe, and effective recanalization was initiated in August 2017 in a team consisting mainly of doctors and co-medical staff of the Stroke Center. In this report, the results of the 17-month trial are reviewed. Methods: In all, 127 patients with acute cerebral artery occlusion who underwent endovascular treatment between January 2016 and December 2018 (56 treated before and 71 treated after the initiation of the time-reducing trial) were compared. Interdepartmental conferences and simulations were frequently held with participation primarily by physicians, radiology technicians, and nurses, and information about treatments, operations by various professionals, and therapeutic approaches was shared. The diagnostic and therapeutic processes of the cases experienced were also promptly evaluated and modified for improvements. Results: The time from the arrival of the patient to the injection of recombinant tissue plasminogen activator (rt-PA) was significantly reduced from 90 to 75 minutes, time from the arrival to puncture from 99 to 74 minutes, procedure time from 63 to 50 minutes, and time from the arrival to eventual recanalization from 165 to 130 minutes. The rate of effective recanalization was higher after the initiation of the trial (62% vs. 76%), but the difference was not significant. The percentage of patients with a favorable outcome was also higher after the initiation of the trial (25% vs. 39%). Conclusion: The results of this study indicate that the time of emergency treatment for acute cerebral artery occlusion can be shortened even in a large-scale university hospital with many constraints by sharing of information among departments and making sure that the medical staff of stroke center is well-informed of the standardized therapeutic approach. stroke team approach, rapid recanalization, therapeutic time
高校医院急性缺血性脑卒中快速再通策略研究
目的:改善急性脑动脉闭塞患者的住院制度和安排,尽快实现脑动脉再通。在埼玉县,在县政府的倡议下,中风应急运输系统于2018年1月开始运行。在我院,2017年8月,一项旨在快速、安全、有效再通的试验在一个主要由中风中心的医生和联合医务人员组成的团队中启动。本报告回顾了17个月试验的结果。方法:对2016年1月至2018年12月期间接受血管内治疗的127例急性脑动脉闭塞患者(缩短时间试验开始前治疗56例,后治疗71例)进行比较。跨部门会议和模拟经常举行,主要由医生、放射技术人员和护士参加,并分享有关治疗、各种专业人员的手术和治疗方法的信息。对所经历的病例的诊断和治疗过程也进行了及时评估和改进。结果:从患者到达到注射重组组织型纤溶酶原激活剂(rt-PA)的时间从90分钟缩短至75分钟,从到达到穿刺时间从99分钟缩短至74分钟,手术时间从63分钟缩短至50分钟,从到达到最终再通时间从165分钟缩短至130分钟。试验开始后,有效再通率更高(62%对76%),但差异不显著。试验开始后,获得良好结果的患者比例也更高(25%对39%)。结论:本研究结果表明,即使是在具有诸多约束条件的大型大学医院,通过科室间信息共享,确保脑卒中中心医务人员了解规范化治疗方法,也可以缩短急性脑动脉闭塞的急诊治疗时间。中风治疗小组入路,快速再通,治疗时间
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
38
审稿时长
17 weeks
期刊介绍: JNET Journal of Neuroendovascular Therapy is the official journal of the Japanese Society for Neuroendovascular Therapy (JSNET). The JNET publishes peer-reviewed original research related to neuroendovascular therapy, including clinical studies, state-of-the-art technology, education, and basic sciences.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信